vancomycin has been researched along with ranalexin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Schuch, R; Wittekind, M | 1 |
| Devocelle, M; Fitzgerald-Hughes, D; Forde, É; Hogan, S; Humphreys, H; O'Gara, JP; O'Neill, E; Zapotoczna, M | 1 |
1 review(s) available for vancomycin and ranalexin
| Article | Year |
|---|---|
Cell wall hydrolases and antibiotics: exploiting synergy to create efficacious new antimicrobial treatments.
Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Bacteriolysis; Cell Wall; Disease Models, Animal; Drug Synergism; Lysostaphin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Peptides, Cyclic; Peptidoglycan; Polymyxin B; Staphylococcal Infections; Vancomycin | 2016 |
2 other study(ies) available for vancomycin and ranalexin
| Article | Year |
|---|---|
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
Eradication of Staphylococcus aureus Biofilm Infections Using Synthetic Antimicrobial Peptides.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Cytokines; Disease Models, Animal; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin | 2017 |